Kinneret Livnat Savitsky
Direktor/Vorstandsmitglied bei Biomica Ltd.
Profil
Kinneret Livnat Savitsky is currently a Director at Biomica Ltd.
She was previously a Director at MabTrix Ltd.
Aktive Positionen von Kinneret Livnat Savitsky
| Unternehmen | Position | Beginn |
|---|---|---|
Biomica Ltd.
 Biomica Ltd. Miscellaneous Commercial ServicesCommercial Services Biomica Ltd. engages in the provision of biopharmaceutical services. Its technology focuses on the development of therapies for antibiotic resistant bacteria, immuno-oncology, and microbiome-related gastrointestinal (GI) disorders. The company was founded by Yehuda Ringel in 2017 and is headquartered in Rehovot, Israel. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Kinneret Livnat Savitsky
| Unternehmen | Position | Ende |
|---|---|---|
MabTrix Ltd.
 MabTrix Ltd. Pharmaceuticals: MajorHealth Technology MabTrix Ltd. develops biopharmaceutical products. It develops innovative function-blocking therapeutic monoclonal antibody for inflammatory bowel disease. The company was founded in December 2015 and is headquartered in Ness Ziona, Israel. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
MabTrix Ltd.
MabTrix Ltd. Pharmaceuticals: MajorHealth Technology MabTrix Ltd. develops biopharmaceutical products. It develops innovative function-blocking therapeutic monoclonal antibody for inflammatory bowel disease. The company was founded in December 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |
Biomica Ltd.
Biomica Ltd. Miscellaneous Commercial ServicesCommercial Services Biomica Ltd. engages in the provision of biopharmaceutical services. Its technology focuses on the development of therapies for antibiotic resistant bacteria, immuno-oncology, and microbiome-related gastrointestinal (GI) disorders. The company was founded by Yehuda Ringel in 2017 and is headquartered in Rehovot, Israel. | Commercial Services |